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Response to Comment on ‘‘Endovascular Treatment of
Profunda Femoris Artery Obstructive Disease:
Nonsense or Useful Tool in Selected Cases?’’Dear Professor Savolainen,
Thank you very much for your interest concerning our paper
entitled: ‘‘Endovascular Treatment of Profunda Femoris
Artery Obstructive Disease: Nonsense or Useful Tool in
Selected Cases?’’1
Our experience with endovascular revascularization of
the profunda femoris artery (PFA) showed 93.3% healing of
minor foot or digital ischemic ulcerations during a mean
follow-up of 29.2 months, in contrast with the results from
your series with a mean follow-up of 5.5 months. One
possible explanation may be the number and quality of
distal ‘‘run off’’ vessels. The Profunda Popliteal Collateral
Index seems to be an excellent predictor for success of
profunda revascularization pre-interventionally. Addition-
ally, the quality and duration of the adjunctive ‘‘best’’
medical treatment can also play an important role. In spite
of our good results we treated only a small cohort of our
patients (those with technically demanding and hazardous
‘‘open’’ repair of PFA) by endovascular means.
Regarding to your second comment we used as reference
the ‘‘old’’ but good study of Kalman et al.2 to emphasize
that ‘‘open’’ profundoplasty has been proven efficient for
over two decades ago reflecting long-term durability of
surgical procedures.
In our paper we concluded that the revascularization of
PFA by ‘‘open’’ techniques remains the gold standard. PTA
of PFA could be offered in carefully selected patients with
technically demanding ‘‘open’’ repair of PFA with rest pain
or minor tissue loss, as bailout treatment.
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Comment on ‘‘Patients Undergoing Cardiac Surgery
with Asymptomatic Unilateral Carotid Stenoses have
a Low Risk of Perioperative Stroke’’Dear Editor,
Although we have appreciated the meaningful paper of
Baiou et al.,1 we are not fully convinced to exclude every
asymptomatic patient from combined carotid endarterec-
tomy (CEA) and cardiac procedures, particularly in candi-
dates to coronary artery bypass grafting (CABG). We have to
consider that a significative number of candidates to CABG
may present cerebrovascular threatening carotid lesions,
even if they have no previous symptoms. In a study on 68
patients who underwent simultaneous CEA and CABG we
reported an unstable or ulcerated carotid plaques in 23 out
of 42 asymptomatic patients (54.7%).2 Moreover, in our
current clinical practice we observe many vulnerable
carotid plaques (ulceration, intra-plaque hemorrhage with
or without rupture of the intima) on CEA þ CABG patients,
which resulted mostly asymptomatic.
Although the evidence of significant benefits from
prophylactic CEA in asymptomatic CABG patients is
controversial, we should be afraid to neglect carotid artery
stenosis with vulnerable plaque. We have probably to
extend the indication to prophylactic CEA for specific
instances of asymptomatic carotid artery lesions, that can
be considered a significant risk of stroke in short and
midterm period after CABG. We would to stress the
opportunity to include a complete preoperative plaque
characterization in the selection of candidates to CABG
with concomitant asymptomatic carotid artery stenosis
providing the right indication for prophylactic CEA.References
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Response to comment on ‘‘Patients undergoing
cardiac surgery with asymptomatic unilateral carotid
stenoses have a low risk of perioperative stroke’’
Dear Sir,
Thank you for your comments regarding our study which
concluded that patients with unilateral, asymptomatic
carotid stenoses undergoing coronary artery bypass grafting
(CABG) have a low risk of stroke.1 You propose that CABG
patients require routine evaluation of plaque morphology
and that prophylactic carotid interventions should be
offered to those with ‘vulnerable’ plaques. However, unless
I am mistaken, no-one has conclusively shown that asymp-
tomatic ‘vulnerable’ plaques pose any greater risk of
procedural stroke during cardiac surgery.
Since our study was published, another has questioned
the role of prophylactic carotid endarterectomy (CEA) or
stenting (CAS) in neurologically asymptomatic patients
undergoing CABG. Li screened 4335 CABG patients for
carotid disease and evaluated the relationship between
post-operative stroke and patterns of carotid disease.2 The
rate of post-CABG stroke was 1.8%, but 95% could not be
attributed to carotid disease. More importantly, none of the
5% whose strokes might have been associated with carotid
disease could have benefited from prophylactic CEA/CAS
(internal carotid artery chronically occluded or <70%
stenosis). Finally, 51 of their patients underwent isolatedDOI of original article: 10.1016/j.ejvs.2010.01.019.CABG with an asymptomatic 70e99% stenosis. None
suffered a stroke. These findings are, of course, identical to
those in our study.
You are not alone in believing that there is a causal
association between carotid disease and post-CABG stroke.
However, a growing body of literature suggests that the
evidence may not support this position. It is important to
remember that the rationale supporting prophylactic CEA/
CAS in CABG patients is to prevent procedural stroke, not late
stroke. Accordingly, a fundamental reappraisal of the
appropriateness of CEA/CAS in CABG patients with asymp-
tomatic, unilateral carotid disease is required. To paraphrase
Roffi, we may be focussing on the wrong culprit (ie carotid
stenosis) instead of addressing the true (and more difficult to
treat) source of embolism, namely the ascending aorta.3
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